The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Cytek BioSciences Inc (NASDAQ: CTKB) closed at $7.04 in the last session, down -1.54% from day before closing price of $7.15. In other words, the price has decreased by -$1.54 from its previous closing price. On the day, 0.91 million shares were traded. CTKB stock price reached its highest trading level at $7.23 during the session, while it also had its lowest trading level at $7.0.
Ratios:
We take a closer look at CTKB’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.26 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 31.53. For the most recent quarter (mrq), Quick Ratio is recorded 5.47 and its Current Ratio is at 6.21. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.07.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stephens on December 14, 2023, initiated with a Overweight rating and assigned the stock a target price of $9.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Apr 19 ’24 when Yan Ming sold 20,000 shares for $5.87 per share. The transaction valued at 117,400 led to the insider holds 5,988,502 shares of the business.
Yan Ming sold 1,900 shares of CTKB for $13,304 on Apr 09 ’24. The CHIEF TECHNOLOGY OFFICER now owns 6,008,502 shares after completing the transaction at $7.00 per share. On Mar 18 ’24, another insider, Yan Ming, who serves as the CHIEF TECHNOLOGY OFFICER of the company, sold 20,000 shares for $6.77 each. As a result, the insider received 135,400 and left with 6,030,402 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CTKB now has a Market Capitalization of 906829440 and an Enterprise Value of 657736896. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.51 while its Price-to-Book (P/B) ratio in mrq is 2.37. Its current Enterprise Value per Revenue stands at 3.269 whereas that against EBITDA is -43.395.
Stock Price History:
Over the past 52 weeks, CTKB has reached a high of $9.87, while it has fallen to a 52-week low of $4.66. The 50-Day Moving Average of the stock is 31.58%, while the 200-Day Moving Average is calculated to be 14.29%.
Shares Statistics:
According to the various share statistics, CTKB traded on average about 673.91K shares per day over the past 3-months and 1190240 shares per day over the past 10 days. A total of 130.71M shares are outstanding, with a floating share count of 116.95M. Insiders hold about 9.21% of the company’s shares, while institutions hold 58.24% stake in the company. Shares short for CTKB as of 1728950400 were 4474407 with a Short Ratio of 6.24, compared to 1726185600 on 4075861. Therefore, it implies a Short% of Shares Outstanding of 4474407 and a Short% of Float of 4.36.
